- Home
- SBFG vs RXST Comparison
SBFG vs RXST Comparison
Compare SBFG & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SBFG | RXST |
|---|---|---|
| Founded | 1983 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.2M | 197.6M |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SBFG | RXST |
|---|---|---|
| Price | $29.55 | $4.91 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $7.57 |
| AVG Volume (30 Days) | 8.2K | ★ 689.0K |
| Earning Date | 10-22-2026 | 11-04-2026 |
| Dividend Yield | ★ 2.18% | N/A |
| EPS Growth | ★ 27.33 | N/A |
| EPS | ★ 1.41 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $5.46 | $9.36 |
| Revenue Next Year | $2.35 | $1.42 |
| P/E Ratio | $20.67 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $18.16 | $4.40 |
| 52 Week High | $30.84 | $13.22 |
Technical Indicators
Market Signals| Indicator | SBFG | RXST |
|---|---|---|
| Relative Strength Index (RSI) | 49.52 | 40.23 |
| Support Level | $28.40 | $4.61 |
| Resistance Level | $30.43 | $4.98 |
| Average True Range (ATR) | 0.87 | 0.22 |
| MACD | -0.09 | 0.04 |
| Stochastic Oscillator | 54.41 | 45.76 |
Price Performance
Historical ComparisonAbout SBFG SB Financial Group Inc.
SB Financial Group Inc that provides a range of community banking services, including commercial and consumer lending, personal and business banking, treasury management and merchant services, personal wealth management and brokerage services, and other financial services to individuals, businesses, and municipalities. It operates in a single segment, which is Banking.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.